Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) - Total Liabilities

Latest as of December 2025: CN¥-6.50 Billion CNY ≈ $-950.98 Million USD

Based on the latest financial reports, Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has total liabilities worth CN¥-6.50 Billion CNY (≈ $-950.98 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Shanghai Allist Pharmaceuticals Co. Ltd. to assess how effectively this company generates cash.

Shanghai Allist Pharmaceuticals Co. Ltd. A - Total Liabilities Trend (2017–2025)

This chart illustrates how Shanghai Allist Pharmaceuticals Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Shanghai Allist Pharmaceuticals Co. Ltd. to evaluate the company's liquid asset resilience ratio.

Shanghai Allist Pharmaceuticals Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shanghai Allist Pharmaceuticals Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Paycom Software, Inc. NYSE:PAYC	USA	$5.87 Billion
Southwest Gas Holdings Inc NYSE:SWX	USA	$6.40 Billion
Urban Outfitters Inc NASDAQ:URBN	USA	$2.20 Billion
ESAB Corp NYSE:ESAB	USA	$2.71 Billion
ViaSat Inc NASDAQ:VSAT	USA	$10.28 Billion
QUBE Holdings Ltd AU:QUB	Australia	AU$3.61 Billion
Jiangsu Yoke Technology Co Ltd SHE:002409	China	CN¥6.59 Billion
Zhuzhou CRRC Times Electric Co Ltd SHG:688187	China	CN¥25.17 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Shanghai Allist Pharmaceuticals Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Allist Pharmaceuticals Co. Ltd. market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.00	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	N/A	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Allist Pharmaceuticals Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)

The table below shows the annual total liabilities of Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥-6.50 Billion ≈ $-950.98 Million	-1126.15%
2024-12-31	CN¥633.32 Million ≈ $92.67 Million	+60.65%
2023-12-31	CN¥394.22 Million ≈ $57.69 Million	+54.52%
2022-12-31	CN¥255.12 Million ≈ $37.33 Million	+62.50%
2021-12-31	CN¥156.99 Million ≈ $22.97 Million	+44.02%
2020-12-31	CN¥109.01 Million ≈ $15.95 Million	-24.31%
2019-12-31	CN¥144.02 Million ≈ $21.07 Million	-52.62%
2018-12-31	CN¥303.96 Million ≈ $44.48 Million	+138.64%
2017-12-31	CN¥127.37 Million ≈ $18.64 Million	--

About Shanghai Allist Pharmaceuticals Co. Ltd. A

SHG:688578 China Biotechnology

Market Cap

$6.29 Billion

CN¥42.99 Billion CNY

Market Cap Rank

#3103 Global

#439 in China

Share Price

CN¥95.53

Change (1 day)

+3.16%

52-Week Range

CN¥83.40 - CN¥118.30

All Time High

CN¥118.30